In the present study, we demonstrated that both β cells in vitro and splenic cells in vivo underwent apoptosis in situations modelling T1D, and the treatment with PRDX6 substantially reduced the diabetogenic apoptosis, thus indicating a protective effect of PRDX6. This evidence concerns the gene PRDX6 and type 1 diabetes mellitus.